Navigation Links
Global CEO Initiative on Alzheimer's Disease (CEOi) Commits Industry to Innovation and Leadership in the Global Fight Against Alzheimer's and Dementia
Date:5/1/2013

General Manager of Health Sciences, Oracle
  • Robert Hormats , Under Secretary, Economic Growth, Energy, and the Environment, U.S. Department of State
  • Sue Siegel , CEO, healthymagination, GE
  • George Vradenburg , Convener, The Global CEO Initiative on Alzheimer's Disease
  • Anne Whitaker , President, North America Pharmaceuticals, Sanofi
  • Cecilia Arradaza , Director, Communications and Policy, FasterCures (moderator)
  • "Alzheimer's is one of the seminal public health issues of our time; the fiscal and social implications cannot be ignored," said Anne Whitaker , President, North America Pharmaceuticals, Sanofi. "From a health perspective and a business perspective, our only option is to pursue a comprehensive framework that includes partnerships, research investments, business models and policy changes to turn this pending crisis into opportunity."

    Alzheimer's and dementia is a global public health priority that requires a global solution.  According to the World Health Organization and the Alzheimer's Disease International 2012 Dementia Report, in 2010, there were approximately 36 million people worldwide suffering from dementia – most diagnosed over the age of 60 – and that number will spike to 115 million by 2050.  Further, the total worldwide costs of dementia, including Alzheimer's disease, were estimated to exceed $600 billion, which is equivalent to one percent of global gross domestic product (GDP).  Combined with a lack of treatment options and the aging of the global population, both prevalence and cost will skyrocket without proper attention and investment.   

    "CEOi intends to utilize our collective expertise across the health, diagnostic, medical, financial services and t
    '/>"/>

    SOURCE The Global CEO Initiative on Alzheimer’s Disease (CEOi)
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
    2. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
    3. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
    4. StemCyte Adds World Class Talent to its North America and Global Operations
    5. Sequenom Named to NASDAQ Global Select Market
    6. Synthetic Biology: Emerging Global Markets
    7. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
    8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
    9. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
    10. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
    11. Accuray Surpasses 600 Installations Globally
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/22/2015)... 22 de enero de 2015  El Dr. Paul ... llamada a nominaciones para 2015. Este prestigioso premio reconoce ... tiene el potencial para hacer, contribuciones destacadas para la ... hasta el 15 de marzo de 2015 a través ...
    (Date:1/22/2015)... 22, 2015   GenoSpace , a precision medicine software company ... the broad use of genomic, imaging and other biomedical data ... Michelle Munson , CEO of Aspera, an IBM Company, ... - http://photos.prnewswire.com/prnh/20150122/170713 "We are pleased ...
    (Date:12/24/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) announced ... has submitted a pre-market approval application to the U.S. ... Medtronic,s SynchroMed ® II implantable drug infusion system ... Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously to ...
    (Date:12/24/2014)... BOTHELL, Wash. , Dec. 24, 2014   BioLife Solutions ... manufacturer and marketer of proprietary clinical grade hypothermic storage ... thermal shipping products for cells and tissues  ("BioLife" or ... Annual Meeting of Stockholders on May 4, 2015 (the "Annual ...
    Breaking Biology Technology:El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4GenoSpace Expands Board with Appointment of Michelle Munson 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4BioLife Solutions Sets Date for Annual Meeting of Stockholders 2
    ... NuMe Health LLC, a biotechnology company developing evidence-based ... disease status by modifying  the bacteria that live ... formation of its scientific advisory board (SAB). NuMe,s SAB ... the fields of nutrition, diabetes, obesity, health promoting ...
    ... 2011 , Spherix Incorporated (NASDAQ: ... therapy in diabetes, metabolic syndrome and atherosclerosis, and providers ... biotechnology and pharmaceutical companies – today announced the closing ... shares of its common stock together with warrants to ...
    ... 28, 2011 Nutra Pharma Corporation (OTCBB: NPHC), ... Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV/AIDS), Adrenomyeloneuropathy ... Executive Officer, Rik J. Deitsch, was interviewed by ... The interview provides an overview of the Company, ...
    Cached Biology Technology:NuMe Health Advances its Cobiotics™ Technology With Addition of Scientific Advisory Board and Filing of Patent Application for First Product 2NuMe Health Advances its Cobiotics™ Technology With Addition of Scientific Advisory Board and Filing of Patent Application for First Product 3NuMe Health Advances its Cobiotics™ Technology With Addition of Scientific Advisory Board and Filing of Patent Application for First Product 4Spherix Announces Closing of Private Placement of $1.25 Million, Discusses Use of Proceeds 2Spherix Announces Closing of Private Placement of $1.25 Million, Discusses Use of Proceeds 3Nutra Pharma CEO Interviewed by Wall Street Reporter 2
    (Date:1/22/2015)... Hall E -   EyeLock Inc. , a market leader ... its EyeLock ID technology integrated in a 3D printed automobile ... Ridge National Laboratory (ORNL) at the 2015 North ... is being used to validate the driver and authorize the ...
    (Date:1/22/2015)... , Jan. 16, 2015  A man-made form of insulin ... other mental capabilities in adults with mild cognitive impairment ... led by researchers at Wake Forest Baptist Medical Center. ... with amnesic mild cognitive impairment (MCI) or mild to ...
    (Date:1/22/2015)... POINT ROBERTS, Washington , January 20, 2015 ... sectors including technology and tech stocks, releases video from the ... pickpocket and security consultant Apollo Robbins . ... about the Wocket™ biometric smart wallet, a product of NXT-ID, ...
    Breaking Biology News(10 mins):EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3
    ... tool developed at the Department of Energy's Pacific Northwest ... machinery of life -- bringing us one step closer ... environment and protecting the country against biological threats. , ... divide the work of analyzing biological data into manageable ...
    ... to implant new FDA-approved device , In a major ... the first hospital in the U.S. to implant into ... the doctor via wireless satellite transmission if the patient's ... battery failure. , When a patient's status changes, a ...
    ... tools for public health officials. As demonstrated during ... can be useful in two ways: they can ... they can allow the comparison of alternative control ... that may systematically bias their predictions, say researchers ...
    Cached Biology News:Genomic sequences processed in minutes, rather than weeks 2New defibrillator signals doctor of patient's irregular heartbeat or device malfunction 2Field of beams - Novel system uses polarized light pulses to reveal crop health 2
    Human RXR beta/NR2B2 MAb (Clone H7341) Keywords: RXRbeta, RXRbeta, Retinoid X Receptor beta...
    Human SOST Affinity Purified Polyclonal Ab...
    BOND ELUT MATRIX-C18, 25 mg ...
    Prepared from plasminogen by activation with immobilized human uPA...
    Biology Products: